Stock Analysis · Bulls vs Bears

Standard Nuclear, Inc. STDN

🐂 Bulls vs Bears 🐻Report #213 Oct 2026
★ Willem owns this stock · 1.3% of the portfolio
60
elevated risk▼ −1 vs last
🐂 9vs11 🐻
Bears lead
33%
▲ Chance of the biggest tailwind the forecasts miss
25%
▼ Chance of the biggest headwind the forecasts miss
The verdict

The operating facts are real. A full commercial core is delivered. Funded backlog grew 15x in five months. Both named customers secured Centrus HALEU contracts in September. There is ~$240M of net cash. But the stock (~$1.86B EV, ~110x FY26 consensus revenue) is ahead of three things that have not happened yet: DOE authorization of SN-TN/SN-ID, a target that has moved four times since February. A first power run of…

The Bulls vs Bears podcast is being made
Two AI hosts debate this report, NotebookLM-style. It appears here automatically within a few hours.

Written by Claude (Anthropic’s AI) from public sources · Willem owns STDN · AI can make mistakes — numbers in brackets point to the sources · Not financial advice

🐂 Bull arguments 9

  1. 1The only merchant TRISO line shipping, and rivals arrive 2028–2031Strong
  2. 2Funded backlog went from $8.2M to $119.3M in five monthsMedium
  3. 3~$240M net cash, no debt, and the plants are already builtStrong
  4. 4Both customers now have Army Janus sites and Centrus HALEU contractsMedium
  5. 5Cheap, fast plants and no uranium-price riskMedium
  6. 6DOE pilot plus an NRC-licensed partner site is a regulatory head startMedium
  7. 7Requalifying fuel for a new supplier takes a year or moreMedium
  8. 8The only non-reactor company in DOE's plutonium negotiationsWeak
  9. 9Sell-side is uniformly positive, Needham sees ~$329M revenue in 2028Weak

🐻 Bear arguments 11

  1. 1~$1.86B EV on $7.5M trailing revenue and $119M firm ordersHigh
  2. 2Q2's 67% gross margin was a timing effect; H1 margin −23%Medium
  3. 3The start-up date has moved four times and DOE alone decidesHigh
  4. 4One customer is 68% of revenue and its reactor hasn't gone criticalHigh
  5. 5The biggest TRISO users make their own fuel; prices will fallMedium
  6. 677% of backlog is options that lapse at end-2027Medium
  7. 7No commercial HALEU before ~2029 caps what customers can orderMedium
  8. 8The operating permission is a free DOE agreement cancellable on 30 days' noticeMedium
  9. 9~146M locked-up shares meet a 10M float around 2027-01-11Medium
  10. 10Customers live on venture money, and USNC died of a failed raiseMedium
  11. 11Founder control, two open material weaknesses, related-party itemsMedium

Bull arguments show how well they survive the devil’s advocate (strong / medium / weak); bear arguments show the damage they could do after the counter-argument (high / medium / low).

Bull case

🐂 Bull #1The only merchant TRISO line shipping, and rivals arrive 2028–2031

  • The point: A microreactor developer that does not make its own fuel has one place in the US to buy commercial-scale TRISO today. The window before a second merchant supplier exists is now better documented than in report #1.
  • Evidence:
    • Standard Nuclear delivered the first complete commercial TRISO core from an independent US maker to Radiant: 50 kgU in Q2 and the rest after quarter-end [1,2].
    • X-energy's TX-1 is "on schedule" for 1H 2028 [26]. Its vertical construction was ~80% done at Q2 [27], and no third-party fuel sale has been announced in its releases [26,27].
    • BWXT's ~$500M Gillette, Wyoming plant has Kairos as its first identified customer [31]. Groundbreaking is expected in 2028 and operation in 2030–31 [31]. On the Q2 call management said it would wait for a firm order pipeline before committing major capital (call summary only) [30]. The BWXT Q2 release does not mention TRISO capacity [29].
    • Needham's 2026-10-06 initiation calls Standard Nuclear the "only merchant fabricator currently delivering commercial shipments of TRISO fuel" (secondhand) [20,21].
  • Why it matters: Fuel has to be specified 1–2 years before a reactor runs [3]. Contracts signed in 2026–2028 therefore run past 2030, so the window turns into multi-year revenue.
  • 😈 Devil's advocate:
    • "Merchant" excludes the biggest users. X-energy, Kairos and Valar make their own fuel (see Bear #5).
    • BWXT already supplied Antares's first critical core [38].
    • By 2030–31 the company becomes one of three or four suppliers just as its larger capacity comes on.
  • Verdict: Strong for 2026–2028. The window is confirmed and slightly longer than assumed in report #1, because BWXT has no FID.

🐂 Bull #2Funded backlog went from $8.2M to $119.3M in five months

  • The point: Orders are binding money, not memoranda.
  • Evidence:
    • Funded backlog was $8.2M (03-31), $61.9M (06-30) and $119.3M (08-26) [1,2].
    • Customer deposits (deferred revenue) rose from $1.1M to $4.0M. Receivables and contract assets rose from $2.3M to $8.1M [1].
    • Contracts include non-refundable deposits up to 24 months before delivery, milestone payments and "off ramp payments" if a customer cancels early. No amounts are disclosed [1].
    • Antares's 1 MTU firm order must be delivered by 2030-12-31 at fixed pricing [1].
  • Why it matters: $119.3M of firm orders is ~16x trailing revenue, and deposits fund working capital before delivery.
  • 😈 Devil's advocate:
    • Interpretation: almost all of the funded growth comes from two contracts.
    • The prospectus says customers may "delay, reduce or terminate" supply agreements [3].
    • Neither contract is filed as an exhibit, so the off-ramp fees cannot be checked [1].
    • The qualified pipeline fell from $986.3M to $696.3M as items converted, so the pool for the next jump is smaller [6].
  • Verdict: Medium It is real money, but concentrated and with unverifiable protections.

🐂 Bull #3~$240M net cash, no debt, and the plants are already built

  • The point: Funding is not the constraint for the 2026–2027 plan.
  • Evidence:
    • Cash was $102.2M at 06-30 plus $137.7M net IPO proceeds, about $239.9M pro forma [1,2].
    • There is no debt and no credit facility [1].
    • SN-TN and SN-ID are "substantially complete" [9].
    • H1 operating cash flow was −$10.9M and capex $17.4M [1].
    • The DOE OTA requires no payment to DOE, though DOE also funds nothing [7].
  • Why it matters:
    • Estimate: at Q2's ~$20M/quarter burn (op CF + capex, derived), cash lasts ~11–12 quarters. At H1's average of ~$14M/quarter it lasts ~16 quarters.
    • Capex should fall now that the two plants are built.
  • 😈 Devil's advocate:
    • Q2 burn was ~2.5x Q1 (derived) and rising.
    • The 10-Q only promises 12 months of coverage [1].
    • SN-TN20 (20 MTU) is "planned and not yet under construction" with no cost given [6]. The 40 MTU ambition clearly needs new equity.
    • The overallotment expired unexercised, so the IPO raised ~$12M less than it could have [1].
  • Verdict: Strong through 2027. It says nothing about funding the 20–40 MTU story.

🐂 Bull #4Both customers now have Army Janus sites and Centrus HALEU contracts

  • The point: The two named customers now have both a government buyer and a feedstock contract. That is a better position than in August.
  • Evidence:
    • On 2026-08-26/27 the Army selected Antares (Fort Bragg) and Radiant (Fort Benning) among five Janus vendors. The program is worth up to $2.2B over FY2027–31, paid by milestone, with a first reactor targeted for September 2028 [37,48].
    • Standard Nuclear itself was not selected; Janus picks reactor makers.
    • Centrus signed HALEU supply contracts with Radiant (2026-09-09) and Antares (2026-09-17), with deliveries starting "prior to the end of the current decade" [34,35].
    • DOE's third HALEU round (2026-07-23) went to Radiant and NASA [36].
  • Why it matters: Interpretation: Standard Nuclear only converts customer-owned uranium. Customers with secured uranium and government revenue are customers who can actually take delivery.
  • 😈 Devil's advocate:
    • The Centrus deliveries are "before end of decade", meaning roughly 2028–2029, and Centrus's cascade has no FY2027 operating funding [33].
    • Janus pays on milestones, and the Army can terminate poor performers and move the money [37].
    • Antares also buys from BWXT [38].
  • Verdict: Medium Feedstock and buyer are better secured than three months ago, but both arrive later than the reactors need them.

🐂 Bull #5Cheap, fast plants and no uranium-price risk

  • The point: Each tonne of capacity costs little and takes about a year to build, and tolling removes commodity risk.
  • Evidence:
    • SN-TN capex was ~$11.9M, and a standard facility takes ~11 months to build [3,6].
    • Customers supply the uranium, so the company carries no feedstock price risk [1].
    • The coating step runs at 95–97% yield [1].
  • Why it matters: Interpretation: at ~$41–57M per MTU (derived from the Antares backlog bridge [1,2]), one 2.5 MTU plant could support ~$100–140M of revenue a year on a capital base of ~$12–20M.
  • 😈 Devil's advocate:
    • Blended yield is only 63.3%, and no target is given [1].
    • H1 gross margin was −23% [1].
    • Tolling also means volume depends entirely on customers' HALEU (Bear #7).
  • Verdict: Medium The economics look attractive on paper but are unproven, because no quarter yet shows them at volume.

🐂 Bull #6DOE pilot plus an NRC-licensed partner site is a regulatory head start

  • The point: Permission to handle HALEU is the slowest gate, and the company has a path at four sites.
  • Evidence:
    • The DOE OTA was signed 2025-09-26, and SN-0 is authorized [7,1].
    • Preliminary safety analyses (PDSAs) for SN-TN and SN-ID are approved [9].
    • The NRC approved the Framatome Richland TRISO amendment in June 2026, meeting the JV's 2027-03-01 milestone early [1,3].
    • By comparison, X-energy needed a 13-month irradiation campaign at INL's test reactor plus an NRC Part 70 licence that it received in February 2026 [26,28].
  • Why it matters: New entrants need years. Interpretation: Richland under an NRC licence is a hedge if DOE policy changes.
  • 😈 Devil's advocate:
    • The two growth plants still need a final safety analysis and a readiness review at DOE's discretion [7].
    • DOE gives the same pilot route to Oklo, Valar and TRISO-X [3].
    • Richland is a 50/50-board JV with dissolution triggers [3].
  • Verdict: Medium

🐂 Bull #7Requalifying fuel for a new supplier takes a year or more

  • The point: Once a reactor is licensed on a given fuel, switching supplier is slow.
  • Evidence:
    • Fuel is made to each customer's specification [1].
    • DOE's AGR program needed roughly two decades of irradiation and examination to qualify TRISO in general [42].
    • X-energy's own commercial fuel qualification includes a 13-month irradiation [28].
    • Refuelling contracts are expected to run "7 to 10 years" (call, partly AI-generated transcript) [14].
  • Why it matters: Interpretation: a reactor fleet licensed on Standard Nuclear fuel gives a decades-long refuelling stream.
  • 😈 Devil's advocate:
    • The AGR data are public, so a new supplier follows a known path [42].
    • Antares already dual-sources [38].
    • The qualification cost of switching was not found.
  • Verdict: Medium The friction is real but not prohibitive for a funded customer.

🐂 Bull #8The only non-reactor company in DOE's plutonium negotiations

  • The point: It is a possible second feedstock outside HALEU.
  • Evidence:
    • In May 2026 DOE picked Oklo, Flibe, Exodys, Shine and Standard Nuclear for "advanced negotiations" on ~20 t of surplus plutonium [44].
    • The company notes it is the only participant without its own reactor [2].
    • It also holds a non-binding Oklo MOU on recycled feedstock (2026-04-13) [1].
  • Why it matters: It would be fuel feedstock that does not depend on enrichment capacity.
  • 😈 Devil's advocate: None of it is a contract or in backlog. Plutonium fuel is politically slow, and Oklo's Aurora uses metal fuel, not TRISO [1].
  • Verdict: Weak It is a free option.

🐂 Bull #9Sell-side is uniformly positive, Needham sees ~$329M revenue in 2028

  • The point: The analysts who model it expect a steep ramp.
  • Evidence:
    • MarketBeat shows 11 ratings (9 Buy, 2 Hold) with an average target of $16.88 and a range of $13–20 [16].
    • StockAnalysis shows 9 analysts with an average of $17.56 [17].
    • Needham initiated at Buy with an $18 target on 10-06. Its revenue path of ~$329M (2028), ~$1.08B (2030) and ~$1.73B (2035) is secondhand and unverified [20,21].
    • CLSA upgraded to Neutral the same day [17].
  • Why it matters: The average target is ~26–31% above $13.38 [19]. The stock rose ~17% on the Needham day [19].
  • 😈 Devil's advocate:
    • Most initiating banks were IPO underwriters, and initiations came the day the quiet period ended [23].
    • Full reports are paywalled.
    • Interpretation: $329M in 2028 needs ~6–7 MTU at ~$50M/MTU, far above the ~1–2 MTU a year in funded orders.
  • Verdict: Weak as evidence. It mainly shows what the price already assumes (see Bear #1).

Bear case

🐻 Bear #1~$1.86B EV on $7.5M trailing revenue and $119M firm orders

  • The point: The price already assumes the 2028+ ramp.
  • Evidence:
    • At $13.38 (2026-10-12) × 156.55M shares, market cap is ~$2.09B [19,1]. Less ~$240M pro forma cash, EV is ~$1.86B (estimate).
    • TTM revenue is $7.54M [18]. FY26 consensus revenue is $16.9M (8 analysts) [17].
    • That makes EV ~247x trailing and ~110x FY26 sales. EV is ~15.6x funded backlog and ~3.2x total backlog.
    • Peers: X-energy is at ~24.7x and BWXT at ~4.1x EV/sales [18].
  • Why it matters: Interpretation: even 3.5 MTU a year fully sold at ~$50M is ~$175M of revenue. The price needs a 10–20 MTU business, which requires microreactor fleets that do not yet exist.
  • 🛡️ Counter-argument: A sole merchant supplier in a policy-backed build-out may justify an option-like premium. Oklo trades at a far higher sales multiple with almost no revenue [18].
  • Severity: High Any delay translates directly into the share price.

🐻 Bear #2Q2's 67% gross margin was a timing effect; H1 margin −23%

  • The point: The "first gross profit" headline overstates the margin.
  • Evidence:
    • Customer-supplied feedstock and work-in-process are not held as inventory [1].
    • Q1 cost of revenue was $5.0M on $0.6M revenue (−743% margin), while the Radiant core was being made.
    • Q2 booked the $3.1M product sale against $1.55M of cost [1,2].
    • H1-26 gross margin was −23%, and FY25 was −144% [1,3].
    • The CFO called Q2 "the model working as designed" and said yield savings will be passed on to customers (call summary) [14,15].
  • Why it matters: Interpretation: anyone extrapolating 67% will be disappointed when Q3/Q4 carry production costs for SN-TN/SN-ID start-up. Operating margin was −91% even in the "good" quarter.
  • 🛡️ Counter-argument: H1 is one core on a 0.5 MTU line at 63% yield. At 2.5 MTU, fixed costs spread out and margins should rise.
  • Severity: Medium High. It does not threaten the business, but it is a likely expectations reset at Q3.

🐻 Bear #3The start-up date has moved four times and DOE alone decides

  • The point: The single most important near-term catalyst has been slipping in quiet steps.
  • Evidence: The SN-TN timeline across filings [8,3,9,1]:
    • February 2026: "operational prior to the completion of this offering".
    • April: "summer of 2026", "fully licensed under DOE authorization".
    • May: completion targeted for June.
    • June/July: "second half of 2026".
    • August: authorization "targeted for the fourth quarter".
    • Final safety analysis and readiness review are still outstanding [1].
    • The 10-Q calls DOE authorization "the primary constraint" on scaling [1].
    • No 8-K has been filed since 2026-09-08 [11].
  • Why it matters: Each quarter of delay keeps capacity at 0.5 MTU/yr, and fixed costs keep growing (G&A $5.5M in Q2 vs $1.0M a year ago [1]).
  • 🛡️ Counter-argument:
    • The target has not formally moved past 2026.
    • The plants copy a working, authorized line.
    • DOE under the current executive orders wants speed.
    • A board member was DOE's chief counsel for nuclear policy until June 2026 [10].
  • Severity: High It sets the FY27 revenue base.

🐻 Bear #4One customer is 68% of revenue and its reactor hasn't gone critical

  • The point: The near-term story rests on Radiant's Kaleidos.
  • Evidence:
    • Customer A was $3.2M of $4.74M Q2 revenue (68%) and Customer C $1.0M (21%) [1]. Interpretation: A is almost certainly Radiant, since Radiant's core was the only product delivery.
    • Kaleidos left El Segundo on 2026-08-12/13 for INL's DOME [39]. Earlier slide targets were fuelling 05-27 and criticality 06-18, both missed before it shipped [39].
    • As of 2026-10-02 no fuelling or criticality had been announced (aggregator) [40]. Radiant had targeted completing the campaign in Q3 [39].
  • Why it matters: A fuel-related test problem would hit Standard Nuclear's reputation directly. A slip pushes Radiant's multi-tonne deliveries through 2031 to the right.
  • 🛡️ Counter-argument:
    • Radiant has a full core in hand, one-year exclusive DOME access, a Janus site and a Centrus HALEU contract [2,37,34].
    • It reportedly raised ~$300M in December 2025, an unverified aggregator figure.
  • Severity: High

🐻 Bear #5The biggest TRISO users make their own fuel; prices will fall

  • The point: The market the company can serve is smaller than the TRISO market.
  • Evidence:
    • X-energy (TX-1, supports ~11 Xe-100s), Kairos (in-house, plus BWXT for Hermes 2) and Valar (on-site plant) are captive [27,31].
    • BWXT fuels its own reactors and supplied Antares's first core [38].
    • The prospectus assumes prices compress as capacity arrives [3].
    • The CEO said "we're going to continue offering lower and lower prices" (call summary) [14].
    • The deck says pricing is "above $50MM" per MTU on near-term firm volume, with lower tiers on larger quantities [6]. Derived from the backlog bridge: the Antares firm tonne is ~$57M and the options ~$41M per MTU [1,2].
  • Why it matters: Volume pricing is already ~28% lower before any competitor sells to outsiders.
  • 🛡️ Counter-argument:
    • Westinghouse eVinci, General Atomics and Nano Nuclear have no signed TRISO supplier.
    • Nano signed a non-binding MOU with Standard Nuclear (10-Q) [1,41].
    • Captive lines often run late, which could create overflow work.
  • Severity: Medium High.

🐻 Bear #677% of backlog is options that lapse at end-2027

  • The point: The $576.9M headline is mostly optional, and the main option has a hard expiry.
  • Evidence:
    • $443.5M of $576.9M is options at customer discretion, and $14.1M is unfunded [6].
    • The Antares options (up to 7 MTU) must be exercised in 1 MTU steps "no later than 2027-12-31", with all 8 MTU delivered by 2030-12-31 [1].
    • The press release said "through 2035" [5]. The 10-Q wording is the binding one, and report #1 used the looser press wording.
  • Why it matters: Interpretation: if Antares has not proven its reactor and secured HALEU by end-2027, most of the options simply lapse. A deadline in 14 months makes the backlog headline fragile.
  • 🛡️ Counter-argument: The CEO said Janus signals drive option exercise (call summary) [14]. Antares has >$600M of backing [5] and a Fort Bragg Janus site [37].
  • Severity: Medium

🐻 Bear #7No commercial HALEU before ~2029 caps what customers can order

  • The point: Customers can only buy fuel for uranium they have.
  • Evidence:
    • DOE "does not currently intend to exercise further options" on Centrus's cascade, and the FY2027 DOE budget has no operating funding for it [33].
    • Centrus's $900M expansion task order targets Piketon commercial production around 2029 [32,33].
    • Radiant's and Antares's Centrus contracts deliver "prior to the end of the current decade" [34,35].
    • DOE allocations are conditional, and quantities are not published [36].
    • Russian-uranium waivers end 2027 [33].
  • Why it matters: Plant capacity of 2.5–3.5 MTU in 2027 may outrun customer feedstock, and option exercise needs uranium first.
  • 🛡️ Counter-argument:
    • Government programs (Janus, NASA) get priority in DOE allocations.
    • Richland's <10% fuel can use LEU+ [1].
    • The company received its own DOE HALEU in December 2025 [1].
  • Severity: Medium High.

🐻 Bear #8The operating permission is a free DOE agreement cancellable on 30 days' notice

  • The point: The OTA is weaker than a licence. Report #1 read only the summary; the exhibit itself is now read.
  • Evidence (OTA exhibit [7]):
    • "Either Party, upon thirty (30) days written notice… with or without cause."
    • Failure to achieve milestones counts as material breach.
    • "DOE does not expect to provide funding."
    • On termination the authority "immediately ceases", and the government bears no costs.
    • Phase I ends 2033-06-30, after which DOE decides "in its sole discretion".
  • Why it matters: About 85–90% of planned 2027 capacity (SN-0, SN-TN, SN-ID) depends on one discretionary federal agreement. A change in administration or a safety event could force a multi-year NRC process.
  • 🛡️ Counter-argument: Current policy strongly backs the pilot. Richland is NRC-licensed. An NRC engagement plan exists [1].
  • Severity: Medium The probability is low but the impact severe.

🐻 Bear #9~146M locked-up shares meet a 10M float around 2027-01-11

  • The point: The supply overhang is large and its date is known.
  • Evidence:
    • Shares outstanding are 156.55M, of which the IPO was 10.0M [1].
    • The 180-day lock-up from 07-15 pricing ends ~2027-01-11. BofA and Goldman can waive it [3].
    • Venture holders' cost was $0.52–4.93 per share. Series A was at $2.5976 and A-2 at $4.932 [1].
    • Decisive Point holds 26.6M shares (17.8%) per its 13G [13].
    • 12.3M options at a $0.61 strike plus 9.13M RSUs make ~13.7% overhang, about 17% including unvested restricted stock [1].
    • No S-3 or ATM is on file [11].
    • Short interest is 3.1M shares, +79% since July (09-30 settlement) [25].
  • Why it matters: Holders with a 3–25x gain face a thin float.
  • 🛡️ Counter-argument:
    • There have been no open-market insider sales. The only "buy" was Decisive Point's 1.28M shares at the IPO price [12].
    • Hendrix's 5.82M "J" transaction was an exchange into Class B, not a sale [12].
  • Severity: Medium It is a stock-price risk, not a business risk.

🐻 Bear #10Customers live on venture money, and USNC died of a failed raise

  • The point: Demand depends on startups raising capital.
  • Evidence:
    • USNC, the predecessor whose assets Standard Nuclear bought, filed Chapter 11 on 2024-10-29 with ~$72.7M of debt after its Series B found no anchor investor [43].
    • The UAMPS/NuScale project was cancelled in 2023 on cost [43].
    • Of the five Janus vendors, three are startups or units without their own cash flow.
  • Why it matters: If capital markets close to nuclear startups, as in 2023, fuel orders slip with them.
  • 🛡️ Counter-argument:
    • The 2026 environment is the opposite. X-energy raised ~$1.1B [26] and Centrus raised capital in September [34].
    • Janus brings federal money from FY2027 [37].
  • Severity: Medium

🐻 Bear #11Founder control, two open material weaknesses, related-party items

  • The point: Outside shareholders have limited say, and the controls are not yet fixed.
  • Evidence:
    • Hendrix holds ~60.8% of votes via 20-vote Class B and can swap up to 4.19M more Class A into Class B. The company is a controlled company [1].
    • Two material weaknesses are not remediated at 06-30: access and segregation of duties, and a lack of GAAP/SEC staff [1].
    • Related-party items [1]:
      • ~$350K paid to Neutroelectric, owned by an officer's spouse.
      • A DOE subaward involving a company whose president was an officer's spouse until 06-30.
      • $2.71M of officer stock loans, repaid at the IPO.
  • Why it matters: One person controls capital allocation, M&A and any sale. Control errors are more likely while the finance team is new; the CFO started in March 2026 [1].
  • 🛡️ Counter-argument: The amounts are small, a CPA-led finance team has been hired, and the board added an ex-TVA CEO [1,3].
  • Severity: Medium Low.

Tailwinds NOT in the forecasts

Context: there is no numeric guidance [2]. Consensus is FY26 revenue $16.9M and EPS −$0.25 (8 analysts) [17]. FY27 EPS is −$0.47 (MarketBeat) [16]. FY27–28 consensus revenue was not found (paywalled). Because EPS is negative, impacts are shown as EBITDA per share, using 156.55M shares. Where consensus for the year is missing, Needham's secondhand FY2028 revenue of ~$329M is used as the reference and labelled as such.

  • A third anchor customer signs a binding supply deal (Nano Nuclear, Westinghouse eVinci, General Atomics, NASA) — 33% chance within 36 months

    • Impact on revenue: ~+$45M in FY2029 (consensus not found; ≈ +14% vs Needham's FY2028 ~$329M as proxy)

    • Impact on EPS: ~+$0.14 EBITDA per share in FY2029 (EPS negative; vs consensus not quantifiable)

    • How we got the number (estimate): 1 MTU/yr × ~$45M/MTU × 50% incremental margin ÷ 156.55M shares ≈ +$0.14

    • Expected value: 0.33 × $0.14 ≈ +$0.05 EBITDA per share

    • What it is: A third name in the funded backlog alongside Radiant and Antares.

    • Why it's not priced in: The Nano relationship is a non-binding MOU disclosed only in the 10-Q [1]. Nano's own release names no fuel vendor [41]. Westinghouse and GA have no named supplier, and analyst models rest on the two signed customers.

    • Trigger to watch: an 8-K converting the Nano MOU, or a Janus vendor naming its fuel supplier.

    • Why this probability: Several buyers lack a supplier and the window favours Standard Nuclear. But Nano's reactor review isn't due until Q3 2027, and Westinghouse and GA have BWXT and in-house options, so slightly below one in three.

  • Antares exercises ≥3 of its 7 option tonnes before the 2027-12-31 deadline — 35% chance by 2027-12-31

    • Impact on revenue: ~+$41M per year in FY2028–30 (≈ +12% vs Needham FY2028 ~$329M proxy)

    • Impact on EPS: ~+$0.13 EBITDA per share per year, FY2028–30

    • How we got the number (estimate): 3 MTU × ~$41M/MTU ÷ 3 delivery years × 50% margin ÷ 156.55M ≈ +$0.13

    • Expected value: 0.35 × $0.13 ≈ +$0.046 EBITDA per share

    • What it is: Options turning into funded backlog.

    • Why it's not priced in: Only partly unpriced. Needham's FY2028 figure probably already includes some option volume, so this counts only for analysts who model funded backlog alone.

    • Trigger to watch: Antares's first Mark-1 power test, and Janus FY2027 milestone payments.

    • Why this probability: Antares has gone critical, has HALEU, money and an Army site, but options must be exercised within 14 months. That is before its HALEU deliveries start.

  • Surplus plutonium contract under DOE's program — 14% chance within 36 months

    • Impact on revenue / EPS: not quantifiable. No volumes, prices or timelines are public.

    • What it is: Turning "advanced negotiations" into an award [44].

    • Why it's not priced in: It is absent from backlog and from analyst commentary.

    • Trigger to watch: a DOE award announcement.

    • Why this probability: Plutonium fuel faces policy, security and non-proliferation scrutiny, and the program has five contenders.

  • Strategic takeover — 7% chance within 36 months

    • Impact on revenue / EPS: not quantifiable (a price premium, not an earnings effect).

    • Why this probability: The asset is strategic, but Hendrix's 60.8% vote control and a fresh IPO with a build-out plan make a sale unlikely.

Headwinds NOT in the forecasts

  • Faster price compression once BWXT or TRISO-X sell to outsiders — 25% chance of a visible cut or lost contract by 2029

    • Impact on revenue: ~−$33M in FY2029 (≈ −10% vs Needham FY2028 ~$329M proxy; FY2029 consensus not found)

    • Impact on EPS: ~−$0.21 EBITDA per share

    • How we got the number (estimate): 10% lower price on ~$329M of revenue = −$33M, all of it lost margin, ÷ 156.55M ≈ −$0.21

    • Expected value: 0.25 × −$0.21 ≈ −$0.053

    • What it is: TX-1's spare capacity or a BWXT Wyoming FID forcing faster price cuts than the company's tiers.

    • Why it's not priced in: Analysts' "only merchant supplier" framing [20] implies a gradual decline.

    • Trigger to watch: X-energy third-party fuel deals, or a BWXT FID announcement.

    • Why this probability: X-energy needs TX-1 for its own reactors first and BWXT has no FID [27,30], so the risk is real but mostly after 2028.

  • Kaleidos test problem or Radiant delivery slip — 25% chance that Radiant defers part of its 2027–28 tonnage

    • Impact on revenue: ~−$25M in FY2028 (≈ −8% vs Needham FY2028 ~$329M proxy)

    • Impact on EPS: ~−$0.09 EBITDA per share

    • How we got the number (estimate): 0.5 MTU deferred × ~$50M/MTU × 55% contribution ÷ 156.55M ≈ −$0.09

    • Expected value: 0.25 × −$0.09 ≈ −$0.022

    • What it is: A fuel-related finding, a long delay at DOME, or a Radiant funding gap.

    • Why it's not priced in: Analysts treat the Radiant agreement as firm backlog. No haircut was found.

    • Trigger to watch: Radiant fuelling and criticality news, and the Q3 product revenue line.

    • Why this probability: First-of-a-kind reactors nearly always slip and Kaleidos already has, but a slip alone does not cancel tonnage.

  • SN-TN/SN-ID authorization slips into mid-2027 or later — 40% chance

    • Impact on revenue: ~−$20M in FY2027 (FY2027 consensus not found)

    • Impact on EPS: ~−$0.08 EBITDA per share in FY2027

    • How we got the number (estimate): ~0.4 MTU of lost output × ~$50M/MTU × 60% contribution ÷ 156.55M ≈ −$0.08

    • Expected value: 0.40 × −$0.08 ≈ −$0.031

    • What it is: The final safety analysis or readiness review takes longer, so capacity stays at 0.5 MTU/yr.

    • Why it's not priced in: The deck target of 2.5 MTU/yr by YE2026 [6] and analyst catalysts [20] assume Q4 2026.

    • Trigger to watch: an authorization 8-K, or the wording at the Q3 call (~November, date TBA).

    • Why this probability: Raised from 33% because the target has moved four times. In addition, no milestone 8-K has come in five weeks, and the readiness review was still open in August.

  • HALEU shortfall delays customers' option exercise — 25% chance

    • Impact on revenue: ~−$40M in FY2028 (≈ −12% vs Needham FY2028 ~$329M proxy)

    • Impact on EPS: ~−$0.13 EBITDA per share

    • How we got the number (estimate): ~1 MTU deferred × ~$41M × 50% ÷ 156.55M ≈ −$0.13

    • Expected value: 0.25 × −$0.13 ≈ −$0.033

    • What it is: Centrus or DOE uranium arrives later than the 2027 option deadline needs.

    • Why it's not priced in: The $443.5M of options is quoted without feedstock caveats.

    • Trigger to watch: DOE allocation rounds, Centrus cascade news, and FY2027 appropriations after the 2026-12-11 continuing-resolution deadline [45].

    • Why this probability: Commercial HALEU is a ~2029 story [32], but government programs get priority.

  • The DOE OTA is ended or authorization withheld — 5% chance within 36 months

    • Impact on revenue: ~−$60M in FY2027 (most of the 2027 capacity; FY2027 consensus not found)

    • Impact on EPS: ~−$0.25 EBITDA per share

    • How we got the number (estimate): ~1.2 MTU lost × $50M × 65% ÷ 156.55M ≈ −$0.25

    • Expected value: 0.05 × −$0.25 ≈ −$0.013

    • Why this probability: Policy is strongly supportive today, so this is a tail risk tied to a safety event or a political change.

  • Equity raise for SN-TN20 / 40 MTU — 45% chance within 36 months

    • Impact on revenue: none directly

    • Impact on EPS: about −10 to −15% per share (dollar amount not meaningful while EPS is negative)

    • How we got the number (estimate): a $250–300M raise at ~$13 ≈ 19–23M new shares ÷ 156.55M ≈ +12–15%

    • Expected value: 0.45 × ~−13% ≈ −6% per share

    • Why this probability: The plan beyond 3.5–5 MTU needs capital the company doesn't have. Management raises only against contracts, and no S-3 is on file [11].

  • Lock-up release (~2027-01-11) — 55% chance of visible VC selling or a secondary within 3 months of expiry

    • Impact on revenue / EPS: not quantifiable. It is a share-supply effect, not an earnings effect.

    • Why this probability: Cost bases are $0.52–4.93 against a $13 share price, and several funds are pre-2025 vehicles. Founder control and a growth narrative may restrain the largest holder.

Investment Risk Score: 60/100 (elevated)

# Factor Weight Measured value Score Why
1 Liquidity & funding runway 15% ~$240M pro forma net cash, no debt; burn ~$20M in Q2 / ~$14M per quarter average in H1 → ~33–50 months runway (estimate) 55 The runway sits at the 36-month line depending on pace. Capex should drop after SN-TN/ID, but start-up costs rise and the 10-Q only promises 12 months.
2 Leverage 10% Net cash; $0 debt; Framatome contingent ≤$6.5M 10 No debt and no facility.
3 Dilution 10% Shares ~+20% in 12 months (estimate: A-2 14.2M + IPO 10M + ~2.4M post-IPO); overhang 13.7–17%; ~$137M RSU expense to come 68 In the 10–25% band. The cheap options and the IPO RSU grant keep it there.
4 Profitability 10% H1-26 gross margin −23%, operating margin −235%, FCF ≈ −$28.4M on $5.3M revenue 78 Clearly loss-making. Q2 "improvement" is mostly cost timing.
5 Revenue quality & concentration 10% Customer A 68% + C 21% of Q2; 100% of product revenue from one customer; 77% of backlog optional 80 More than 35% from one customer, and backlog rests on two startups.
6 Execution & track record 10% SN-TN start moved 4 times (pre-IPO → Q4 authorization); 2 material weaknesses open; first core delivered as promised 70 Repeated quiet slips and open controls, offset by on-time core delivery and two signed contracts.
7 Competitive position & disruption 10% Only merchant line shipping; TRISO-X 1H-28 captive; BWXT Wyoming 2030–31, no FID; largest users captive 50 A strong niche today, contested from 2028–30, with management guiding prices lower.
8 Cyclicality & commodity/macro sensitivity 10% No uranium-price risk (tolling); demand tied to venture funding and federal budgets; USNC failed on a raise 55 Sensitive to capital-market cycles through its customers rather than to commodities.
9 Regulatory, legal & geopolitical 5% Authorization pending at DOE discretion; OTA cancellable on 30 days; HALEU dependency; Russian waivers end 2027; no litigation 65 A large pending ruling sets 2027 capacity.
10 Valuation & expectations 10% EV $1.86B ≈ 247x TTM sales / ~110x FY26 consensus; 15.6x funded backlog; short interest 3.1M (3–6% of float) 78 Priced for a 10–20 MTU future. Short interest is modest, but the float is thin before the lock-up.

Overall: 0.15×55 + 0.10×10 + 0.10×68 + 0.10×78 + 0.10×80 + 0.10×70 + 0.10×50 + 0.10×55 + 0.05×65 + 0.10×78 = 60.4 → 60.

Change vs last: −1 (61 → 60). Report #1 used the old 6-area method.

  • Lower: net cash now scores separately (Leverage 10), and so does tolling (Cyclicality 55 instead of a general "dependency" score).
  • Higher: the hard evidence on margin timing (Profitability 78), Customer A 68% (Concentration 80) and the four-step start-up slip (Execution 70).

Ranking check: Score 60 puts STDN between EROC (58) and FRVO (61).

  • It is riskier than EROC: EROC has hundreds of millions in revenue, while STDN has $7.5M at ~247x sales.
  • It is safer than FRVO: STDN has 33–50 months of runway versus FRVO's ~13–15, and a much smaller unfunded build.

Conclusion

  • What you are really betting on: that US microreactors move from zero-power tests to serial deployment by 2028–2030, and that Standard Nuclear captures most of the merchant fuel volume before BWXT and TRISO-X sell to outsiders. The plant, the cash and the first two customers exist. The industry that needs 10+ MTU a year does not yet.

  • The 2–3 things that will decide the outcome:

    1. DOE authorization of SN-TN/SN-ID and the Q3/Q4 cost and margin picture.
    2. Kaleidos and Antares reactors running at power on its fuel, which drives option exercise before the 2027-12-31 deadline.
    3. A third binding customer before 2028.

  • Signposts — confirming the bull case:

    • An authorization 8-K for SN-TN/SN-ID by YE2026, with blended yield above 70%.
    • Kaleidos criticality and the 150-hour run completed on Standard Nuclear fuel.
    • Nano Nuclear's MOU, or a Janus vendor, converted into a funded supply deal.
    • Antares option tonnes moved into funded backlog during 2027.

  • Signposts — breaking the bull case:

    • The Q3 call moves authorization to "2027", or the target is dropped.
    • Q3/Q4 gross margin is deeply negative and yield is stuck near 63%.
    • Radiant defers tonnage, or a fuel-related finding emerges at DOME.
    • A BWXT Wyoming FID or X-energy third-party contracts at lower prices, or heavy VC selling or a secondary right after the January lock-up.

  • New since the last report:

    • Q2's 67% gross margin is mainly a timing effect. Q1 carried the Radiant core's costs, and H1 gross margin was −23%.
    • The Antares options lapse at 2027-12-31 and deliveries end 2030, not 2035. The SN-TN start target has moved four times since February. The OTA exhibit shows DOE gives no money and can treat a missed milestone as a breach.
    • Both customers signed Centrus HALEU contracts in September. Nano Nuclear has a non-binding MOU. BWXT Wyoming has no FID (operation 2030–31). The overallotment expired unexercised.

Open questions & data gaps

  • Radiant and Antares contract terms (price tiers, take-or-pay, off-ramp fee size, exclusivity) are not filed as exhibits. This matters a lot: it decides how firm the $119.3M really is.
  • No verbatim Q2 call transcript. Only partly AI-generated or summarised versions were readable, so call quotes [14,15] may be imperfect.
  • FY2027–28 consensus revenue was not found (paywalled). Needham's ~$329M FY2028 is secondhand. Tailwind and headwind sizing uses it as a proxy.
  • Kaleidos status after early October is unconfirmed. Radiant's and INL's pages returned 403. An aggregator says DOME's next availability is July 2027, which is unverified.
  • The Q3 date has not been announced. Third-party estimates are 11-20 and 11-25.
  • Free float is inconsistent across sources (51.9M at StockAnalysis vs ~100M at Stock Titan), so short interest as a % of float is uncertain (3–6%).
  • Richland "operable equipment by 2026-12-01" milestone: no status disclosed.
  • Customer C ($1.0M in Q2) is unidentified.
Sources
  1. Standard Nuclear Form 10-Q, quarter ended 2026-06-30 — SEC EDGAR — 2026-08-27 — https://www.sec.gov/Archives/edgar/data/2086716/000162828026059189/nucl-20260630.htm
  2. Standard Nuclear Reports Second Quarter and Year-to-Date 2026 Results (8-K Ex. 99.1) — Standard Nuclear / SEC — 2026-08-26 — https://www.sec.gov/Archives/edgar/data/0002086716/000162828026059143/q2_2026xearningsxpr.htm
  3. Standard Nuclear Form 424B4 prospectus — SEC EDGAR — 2026-07-16 — https://www.sec.gov/Archives/edgar/data/2086716/000121390026078747/ea0276071-13.htm
  4. Standard Nuclear and Radiant fuel sale agreement (8-K Ex. 99.1) — Standard Nuclear / SEC — 2026-08-20 — https://www.sec.gov/Archives/edgar/data/0002086716/000162828026058139/radiant_fuelxsalexagreement.htm
  5. Standard Nuclear Announces Fuel Supply Agreement with Antares Nuclear (8-K Ex. 99.1) — Standard Nuclear / SEC — 2026-08-27 — https://www.sec.gov/Archives/edgar/data/2086716/000162828026059165/antares_fuelxsupplyxagreem.htm
  6. Investor Presentation, September 2026 (8-K Item 7.01) — Standard Nuclear — 2026-09-08 — https://d1io3yog0oux5.cloudfront.net/_135e1a9bfa0a91fdda0b289e0381ad25/standardnuclear/db/3576/34487/pdf/Standard-Nuclear-Investor-Presentation-September-2026.pdf
  7. Other Transaction Agreement for Fuel Production Line Authorization (Ex. 10.6 to S-1/A) — DOE / Standard Nuclear — dated 2025-09-26, filed 2026-07-07 — https://www.sec.gov/Archives/edgar/data/2086716/000121390026075742/ea027607111ex10-6.htm
  8. Draft registration statements (DRS 2026-02-13; DRS/A 2026-04-10, 2026-05-05, 2026-06-02) — SEC EDGAR — 2026 — https://www.sec.gov/Archives/edgar/data/2086716/000121390026016600/filename1.htm ; https://www.sec.gov/Archives/edgar/data/2086716/000121390026042144/filename1.htm ; https://www.sec.gov/Archives/edgar/data/2086716/000121390026051869/filename1.htm ; https://www.sec.gov/Archives/edgar/data/2086716/000121390026064221/filename1.htm
  9. Facilities construction and PDSA approval press release (8-K) — Standard Nuclear / SEC — 2026-07-22 — https://www.sec.gov/Archives/edgar/data/2086716/000162828026049125/standardnuclearpr_licens.htm
  10. Form 8-K, appointment of Seth Cohen to the board — SEC EDGAR — 2026-08-14 — https://www.sec.gov/Archives/edgar/data/2086716/000162828026056936/stdn-20260812.htm
  11. EDGAR filing list and submissions API, CIK 0002086716 — SEC — accessed 2026-10-13 — https://data.sec.gov/submissions/CIK0002086716.json
  12. Forms 4 (Hendrix 0001628280-26-048735; Terrani; Decisive Point; Fundomo; Welara) — SEC EDGAR — 2026-07-17 to 2026-08-28 — https://www.sec.gov/Archives/edgar/data/2086716/000162828026048735/wk-form4_1784336380.xml
  13. Schedule 13G, Decisive Point Group (accession 0001193125-26-314667) — SEC EDGAR — 2026-07-23 — https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0002086716
  14. Earnings call transcript: Standard Nuclear posts Q2 2026 revenue surge (partly AI-generated) — Investing.com — 2026-08-27 — https://www.investing.com/news/transcripts/earnings-call-transcript-standard-nuclear-posts-q2-2026-revenue-surge-93CH-4879621
  15. Standard Nuclear Q2 2026 call (summaries) — StockAnalysis / Quartr — 2026-08-27 — https://stockanalysis.com/stocks/stdn/transcripts/733288-q2-2026/ ; https://quartr.com/events/standard-nuclear-inc-stdn-q2-2026_F1JDVrLs
  16. STDN analyst ratings, forecast and earnings — MarketBeat — accessed 2026-10-13 — https://www.marketbeat.com/stocks/NYSE/STDN/forecast/
  17. STDN forecast (consensus revenue/EPS, ratings) — StockAnalysis — accessed 2026-10-13 — https://stockanalysis.com/stocks/stdn/forecast/
  18. Statistics pages for STDN, BWXT, LEU, XE, OKLO, NNE — StockAnalysis — close 2026-10-12 — https://stockanalysis.com/stocks/stdn/statistics/
  19. STDN price history — StockAnalysis — 2026-08-03 to 2026-10-12 — https://stockanalysis.com/stocks/stdn/history/
  20. Standard Nuclear (STDN) Shares Surge 10.8% After Needham Initiates Coverage with Buy — GuruFocus — 2026-10-06 — https://www.gurufocus.com/news/9111932/standard-nuclear-stdn-shares-surge-108-after-needham-initiates-coverage-with-buy
  21. Analyst Says Standard Nuclear Is the Only Company Shipping a Key Advanced-Reactor Fuel (search snippet only) — Benzinga — 2026-10-06 — https://www.benzinga.com/analyst-stock-ratings/initiation/26/10/62224150/analyst-says-standard-nuclear-is-the-only-company-shipping-a-key-advanced-reactor-fuel
  22. Fuel Maker Standard Nuclear Declines After Downsized IPO — Bloomberg Law — 2026-07-16 — https://news.bgov.com/capital-markets/fuel-maker-standard-nuclear-declines-10-after-downsized-ipo
  23. Is Standard Nuclear's $150M TRISO IPO a Vote of Confidence or a Discounted Warning Sign? — SMR Intel — 2026-07-17 — https://smrintel.com/news/standard-nuclear-stdn-ipo-150-million-triso-fuel
  24. Standard Nuclear: Worth Keeping An Eye On, But Not Going To Invest Yet (snippet only) — Seeking Alpha — 2026-08-28 — https://seekingalpha.com/symbol/STDN
  25. STDN short interest (settlement 2026-09-30) — StockMarketWatch / Stock Titan — 2026-10 — https://stockmarketwatch.com/stock/STDN/short-interest
  26. X-energy Q1 2026 results (8-K Ex. 99.1) — SEC EDGAR — 2026-06-04 — https://www.sec.gov/Archives/edgar/data/0002088896/000119312526256369/xe-ex99_1.htm
  27. X-Energy Q2 Earnings Call Highlights (summary) — MarketBeat — 2026-08-13 — https://www.marketbeat.com/instant-alerts/x-energy-q2-earnings-call-highlights-2026-08-13/
  28. X-energy begins commercial qualification testing for TRISO-X fuel at INL — X-energy — 2025-11-06 — https://x-energy.com/news/x-energy-begins-commercial-qualification-testing-for-triso-x-fuel-at-idaho-national-laboratory/
  29. BWXT Q2 2026 results (8-K Ex. 99.1) — SEC EDGAR — 2026-08-03 — https://www.sec.gov/Archives/edgar/data/0001486957/000148695726000041/bwxt_63026xerexhibit991.htm
  30. BWXT's Q2 earnings call: our top 5 analyst questions (summary only) — Barchart — 2026-08 — https://www.barchart.com/story/news/3750901/bwxs-q2-earnings-call-our-top-5-analyst-questions
  31. BWXT has first customer for its $500 million nuclear fuel plant in Gillette — Cowboy State Daily — 2026-05-06 — https://cowboystatedaily.com/2026/05/06/bwxt-has-first-customer-for-its-500-million-nuclear-fuel-plant-in-gillette/
  32. Centrus Energy Q2 2026 results (8-K Ex. 99.1) — SEC EDGAR — 2026-08-05 — https://www.sec.gov/Archives/edgar/data/0001065059/000162828026053433/ex991-10q2026_08x05.htm
  33. Centrus Energy Form 10-Q, quarter ended 2026-06-30 — SEC EDGAR — 2026-08-06 — https://www.sec.gov/Archives/edgar/data/1065059/000162828026053863/leu-20260630.htm
  34. Centrus 8-K, HALEU supply contract with Radiant; offering — SEC EDGAR — 2026-09-09 — https://www.sec.gov/Archives/edgar/data/1065059/000162828026061036/leu-20260909.htm
  35. Centrus 8-K, HALEU supply contract with Antares — SEC EDGAR — 2026-09-17 — https://www.sec.gov/Archives/edgar/data/1065059/000162828026062535/leu-20260917.htm
  36. Energy Department to Distribute Third Round of HALEU to NASA and Radiant — US DOE — 2026-07-23 — https://www.energy.gov/ne/articles/energy-department-distribute-third-round-haleu-nasa-and-radiant
  37. US nuclear microreactors to power Army bases (Janus awards) — The Defense Post — 2026-08-28 — https://thedefensepost.com/2026/08/28/us-nuclear-microreactors-base-2/
  38. Department of Energy Celebrates Fourth Criticality Ahead of July 4th Goal — US DOE — 2026-07-06 — https://www.energy.gov/articles/department-energy-celebrates-fourth-criticality-ahead-july-4th-goal ; BWXT Manufactures TRISO Fuel Enabling First New Reactor Criticality Under DOE Program — BWXT / Business Wire — 2026-06-04 — https://www.businesswire.com/news/home/20260604742514/en/
  39. Kaleidos moves to Idaho test facility — NEI Magazine — 2026-08-21 — https://www.neimagazine.com/news/kaleidos-moves-to-idaho-test-facility/
  40. Radiant Nuclear company profile and milestones (aggregator; treat as lead) — Venture Atlas — 2026-10-02 — https://www.ventureatlas.org/company/radiant-nuclear
  41. NANO Nuclear Q3 FY2026 results (8-K Ex. 99.1) — SEC EDGAR — 2026-08-12 — https://www.sec.gov/Archives/edgar/data/0001923891/000149315226037746/ex99-1.htm
  42. AGR TRISO Fuel Development and Qualification Program overview (Demkowicz) — US DOE — 2015 — https://www.energy.gov/sites/default/files/2015/10/f27/Demkowicz%20%20AGR%20overview.pdf
  43. Major microreactor developer enters bankruptcy amid nuclear industry surge — POWER Magazine — 2024-10/11 — https://www.powermag.com/major-microreactor-developer-enters-bankruptcy-amid-nuclear-industry-surge ; NuScale cancels first-of-a-kind nuclear project as costs surge — E&E News — 2023-11 — https://www.eenews.net/articles/nuscale-cancels-first-of-a-kind-nuclear-project-as-costs-surge/
  44. DOE selects five companies to negotiate receipt of surplus US plutonium — ANS Nuclear Newswire — 2026-05-28 — https://www.ans.org/news/2026-05-28/article-8075/doe-selects-five-companies-to-negotiate-receipt-of-surplus-us-plutonium/
  45. President Trump signs continuing resolution to fund government through December 11 — AACOM — 2026-09-08 — https://www.aacom.org/news-reports/news/2026/09/08/president-trump-signs-continuing-resolution-to-fund-government-through-december-11
  46. Proposed FY 2027 DOE, NRC budgets ask for less — ANS Nuclear Newswire — 2026-04-07 — https://www.ans.org/news/2026-04-07/article-7915/proposed-fy-2027-doe-nrc-budgets-ask-for-less/
  47. Standard Nuclear (STDN) data page (AI-generated; indicative only) — Trefis — 2026-10-12 — https://www.trefis.com/data/companies/STDN
  48. Five companies, five bases: The Army's Janus Program takes shape (paywalled excerpt) — ANS Nuclear Newswire — 2026-08-28 — https://www.ans.org/news/2026-08-28/article-8347/five-companies-five-bases-the-armys-janus-program-takes-shape/
All STDN Bulls vs Bears reports
Disclaimer. AI-generated research and podcast (Claude by Anthropic, voices by Google Gemini) for educational purposes — not financial advice and not a recommendation to buy or sell. Willem (MR.INVEST) owns this stock. Check the company’s own filings before making any decision.
← All Bulls vs Bears reports